$4.08
0.12%
Nasdaq, Nov 18, 03:59 pm EST. Closed.
ISIN
US56400P7069
Symbol
MNKD

MannKind Corporation Stock price

$4.07
+0.98 31.72% 1M
+1.08 36.12% 6M
-1.60 28.22% YTD
-0.99 19.57% 1Y
+0.31 8.24% 3Y
-0.64 13.59% 5Y
+0.96 30.66% 10Y
-84.83 95.42% 20Y
Nasdaq, Closing price Wed, Nov 18 2026
+0.00 0.00%
ISIN
US56400P7069
Symbol
MNKD
Industry

Is MannKind Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,090 stocks worldwide.

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$1.8b
Net debt
$458.8m
Cash
$111.1m
Shares outstanding
309.9m
Valuation
P/E
negative
P/S | estimate
3.3 | 2.9
EV/Sales | estimate
4.5 | 4.0
EV/FCF | ex SBC
negative | negative
P/B
negative
Financial Health
Equity Ratio
-6.4%
Return on Equity
-11.5%
ROCE
2.3%
ROIC
2.2%
Debt/Equity
-8.5
Share-Based Compensation & Dilution
SBC | % of Revenue
$28.0m | 7.1%
SBC as % of FCF
-
SBC Growth 1Y
16.7%
Share Count Growth 1Y
1.2%
Shareholder Yield
-1.2%
Financials
Revenue | estimate
$393.6m | $445.5m
EBITDA
$26.2m
EBIT
$13.5m
Net Income
$-42.8m
Free Cash Flow | ex SBC
$-18.1m | $-46.1m
Growth
Revenue | estimate
30.5% | 27.7%
EBITDA
-70.3%
EBIT
-83.1%
Net Income
-232.4%
Free Cash Flow
-163.0%
Margin
Gross
76.8%
EBITDA
6.7%
EBIT
3.4%
Net
-10.9%
Free Cash Flow | ex SBC
-4.6% | -11.7%
More
EPS
$-0.1
FCF per Share
$-0.1
Short interest
8.3%
Employees
592
Rev per Employee
$590.0k

MannKind Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a MannKind Corporation forecast:

13x Buy
87%
2x Hold
13%

Analyst Opinions

15 Analysts have issued a MannKind Corporation forecast:

Buy
87%
Hold
13%

MannKind Corporation Events

Past Events
NOV
5
Q3 2026 Earnings Call
13 days ago
AUG
5
Q2 2026 Earnings Call
4 months ago
JUL
29
Special Call - MannKind Corporation
4 months ago
JUL
24
Special Call - MannKind Corporation
4 months ago
MAY
29
Special Call - MannKind Corporation
6 months ago
MAY
6
Q1 2026 Earnings Call
7 months ago
MAR
11
Barclays 28th Annual Global Healthcare Conference
8 months ago
FEB
26
Q4 2025 Earnings Call
9 months ago
NOV
10
Special Call - MannKind Corporation
about one year ago
NOV
5
Q3 2025 Earnings Call
about one year ago

Financial data from MannKind Corporation

Jun '26
+/-
%
394 394
30% 30%
100%
- Direct Costs 91 91
34% 34%
23%
302 302
29% 29%
77%
- Selling and Administrative Expenses 199 199
90% 90%
51%
- Research and Development Expense 77 77
58% 58%
20%
26 26
70% 70%
7%
- Depreciation and Amortization 13 13
50% 50%
3%
EBIT (Operating Income) EBIT 13 13
83% 83%
3%
Net Profit -43 -43
232% 232%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about MannKind Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MannKind Corporation Stock News

Neutral
GlobeNewsWire
●
about one month ago
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced that Chief Executive Officer Michael Castagna will participate in a panel focused on innovation across chronic respiratory diseases at the Chardan Healthcare Conference. Management will also participate in one-on-one meetings with investors during the conference.
Neutral
GlobeNewsWire
●
2 months ago
Collaboration combines Rose Pharma investigational rapid-acting GLP-1 receptor agonist with MannKind's Technosphere ® inhalation technology MannKind to receive an equity interest and potential royalties while providing pharmaceutical development and manufacturing support through completion of a Phase 1b clinical study DANBURY, Conn. and WESTLAKE VILLAGE, Calif.
More MannKind Corporation News

Company Profile

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.

Head office United States
CEO Dr. Castagna
Employees 592
Founded 1991
Website mannkindcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today